Medications

Iron chelation therapy treats iron overload in MDS

(HealthDay)—Iron chelation therapy (ICT) seems beneficial for iron-overloaded patients with low- or intermediate-1-risk myelodysplastic syndromes (MDS), according to a study published online March 24 in the Annals of Internal ...

Medical research

New and better marker for assessing patients after cardiac arrest

Last year, researchers Tobias Cronberg and Niklas Mattsson at Lund University in Sweden published a study showing serum tau levels to be a new and promising marker for identifying patients with severe brain damage after cardiac ...

Medications

Zoledronic acid linked to early increase in sclerostin levels

(HealthDay)—Women with postmenopausal osteoporosis treated with zoledronic acid show an early increase in serum levels of the negative regulator of bone formation, sclerostin, that return close to baseline after 360 days, ...

Oncology & Cancer

FSH, inhibin B poor predictors of sperm count after cancer

(HealthDay)—Serum levels of follicle-stimulating hormone (FSH) and inhibin B are not good predictors of sperm levels in male survivors of childhood cancer, according to a study published online Feb. 19 in the Journal of ...

Diseases, Conditions, Syndromes

Phototherapy affects serum 25(OH)D levels

(HealthDay)—For patients with inflammatory skin conditions, phototherapy with ultraviolet (UV) A1 radiation induces a reduction in serum 25-hydroxyvitamin D3 (25[OH]D) levels, whereas narrowband UVB (UVBnb) and UVA/UVBnb ...

Diseases, Conditions, Syndromes

Low-dose rifaximin cuts endotoxin level in cirrhosis

(HealthDay)—For patients with liver cirrhosis, low-dose rifaximin is comparable to high-dose rifaximin for reducing serum endotoxin levels, according to a study published online Oct. 16 in the Journal of Digestive Diseases.

page 9 from 11